Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 69

1.

Metformin prevents liver tumourigenesis by attenuating fibrosis in a transgenic mouse model of hepatocellular carcinoma.

Shankaraiah RC, Callegari E, Guerriero P, Rimessi A, Pinton P, Gramantieri L, Silini EM, Sabbioni S, Negrini M.

Oncogene. 2019 Aug 13. doi: 10.1038/s41388-019-0942-z. [Epub ahead of print]

PMID:
31409896
2.

Whole metagenomic shotgun sequencing of the subgingival microbiome of diabetics and non-diabetics with different periodontal conditions.

Farina R, Severi M, Carrieri A, Miotto E, Sabbioni S, Trombelli L, Scapoli C.

Arch Oral Biol. 2019 Aug;104:13-23. doi: 10.1016/j.archoralbio.2019.05.025. Epub 2019 May 25.

PMID:
31153098
3.

MicroRNA-Based Prophylaxis in a Mouse Model of Cirrhosis and Liver Cancer.

Callegari E, Domenicali M, Shankaraiah RC, D'Abundo L, Guerriero P, Giannone F, Baldassarre M, Bassi C, Elamin BK, Zagatti B, Ferracin M, Fornari F, Altavilla G, Blandamura S, Silini EM, Gramantieri L, Sabbioni S, Negrini M.

Mol Ther Nucleic Acids. 2019 Mar 1;14:239-250. doi: 10.1016/j.omtn.2018.11.018. Epub 2018 Dec 6.

4.

miR-199a-3p Modulates MTOR and PAK4 Pathways and Inhibits Tumor Growth in a Hepatocellular Carcinoma Transgenic Mouse Model.

Callegari E, D'Abundo L, Guerriero P, Simioni C, Elamin BK, Russo M, Cani A, Bassi C, Zagatti B, Giacomelli L, Blandamura S, Moshiri F, Ultimo S, Frassoldati A, Altavilla G, Gramantieri L, Neri LM, Sabbioni S, Negrini M.

Mol Ther Nucleic Acids. 2018 Jun 1;11:485-493. doi: 10.1016/j.omtn.2018.04.002. Epub 2018 Apr 12.

5.

Circulating miR-106b-3p, miR-101-3p and miR-1246 as diagnostic biomarkers of hepatocellular carcinoma.

Moshiri F, Salvi A, Gramantieri L, Sangiovanni A, Guerriero P, De Petro G, Bassi C, Lupini L, Sattari A, Cheung D, Veneziano D, Nigita G, Shankaraiah RC, Portolani N, Carcoforo P, Fornari F, Bolondi L, Frassoldati A, Sabbioni S, Colombo M, Croce CM, Negrini M.

Oncotarget. 2018 Feb 27;9(20):15350-15364. doi: 10.18632/oncotarget.24601. eCollection 2018 Mar 16.

6.

Non-coding RNAs in the reprogramming of glucose metabolism in cancer.

Shankaraiah RC, Veronese A, Sabbioni S, Negrini M.

Cancer Lett. 2018 Apr 10;419:167-174. doi: 10.1016/j.canlet.2018.01.048. Epub 2018 Jan 31. Review.

PMID:
29366802
7.

Anti-leukemic activity of microRNA-26a in a chronic lymphocytic leukemia mouse model.

D'Abundo L, Callegari E, Bresin A, Chillemi A, Elamin BK, Guerriero P, Huang X, Saccenti E, Hussein EMAA, Casciano F, Secchiero P, Zauli G, Calin GA, Russo G, Lee LJ, Croce CM, Marcucci G, Sabbioni S, Malavasi F, Negrini M.

Oncogene. 2017 Nov 23;36(47):6617-6626. doi: 10.1038/onc.2017.269. Epub 2017 Aug 7.

8.

Circulating MicroRNA Quantification Using DNA-binding Dye Chemistry and Droplet Digital PCR.

Ferracin M, Salamon I, Lupini L, Miotto E, Sabbioni S, Negrini M.

J Vis Exp. 2016 Jun 26;(112). doi: 10.3791/54102.

9.

Over-expression of the miR-483-3p overcomes the miR-145/TP53 pro-apoptotic loop in hepatocellular carcinoma.

Lupini L, Pepe F, Ferracin M, Braconi C, Callegari E, Pagotto S, Spizzo R, Zagatti B, Lanuti P, Fornari F, Ghasemi R, Mariani-Costantini R, Bolondi L, Gramantieri L, Calin GA, Sabbioni S, Visone R, Veronese A, Negrini M.

Oncotarget. 2016 May 24;7(21):31361-71. doi: 10.18632/oncotarget.8913.

10.

Prediction of response to anti-EGFR antibody-based therapies by multigene sequencing in colorectal cancer patients.

Lupini L, Bassi C, Mlcochova J, Musa G, Russo M, Vychytilova-Faltejskova P, Svoboda M, Sabbioni S, Nemecek R, Slaby O, Negrini M.

BMC Cancer. 2015 Oct 27;15:808. doi: 10.1186/s12885-015-1752-5.

11.

Epstein-Barr Virus MicroRNAs are Expressed in Patients with Chronic Lymphocytic Leukemia and Correlate with Overall Survival.

Ferrajoli A, Ivan C, Ciccone M, Shimizu M, Kita Y, Ohtsuka M, D'Abundo L, Qiang J, Lerner S, Nouraee N, Rabe KG, Rassenti LZ, Van Roosbroeck K, Manning JT, Yuan Y, Zhang X, Shanafelt TD, Wierda WG, Sabbioni S, Tarrand JJ, Estrov Z, Radovich M, Liang H, Negrini M, Kipps TJ, Kay NE, Keating M, Calin GA.

EBioMedicine. 2015 Apr 29;2(6):572-82. doi: 10.1016/j.ebiom.2015.04.018. eCollection 2015 Jun.

12.

Diagnostic and prognostic microRNAs in the serum of breast cancer patients measured by droplet digital PCR.

Mangolini A, Ferracin M, Zanzi MV, Saccenti E, Ebnaof SO, Poma VV, Sanz JM, Passaro A, Pedriali M, Frassoldati A, Querzoli P, Sabbioni S, Carcoforo P, Hollingsworth A, Negrini M.

Biomark Res. 2015 Jun 6;3:12. doi: 10.1186/s40364-015-0037-0. eCollection 2015.

13.

miR-181b as a therapeutic agent for chronic lymphocytic leukemia in the Eµ-TCL1 mouse model.

Bresin A, Callegari E, D'Abundo L, Cattani C, Bassi C, Zagatti B, Narducci MG, Caprini E, Pekarsky Y, Croce CM, Sabbioni S, Russo G, Negrini M.

Oncotarget. 2015 Aug 14;6(23):19807-18.

14.

Inhibiting the oncogenic mir-221 by microRNA sponge: toward microRNA-based therapeutics for hepatocellular carcinoma.

Moshiri F, Callegari E, D'Abundo L, Corrà F, Lupini L, Sabbioni S, Negrini M.

Gastroenterol Hepatol Bed Bench. 2014 Winter;7(1):43-54.

15.

MicroRNAs in liver cancer: a model for investigating pathogenesis and novel therapeutic approaches.

Callegari E, Gramantieri L, Domenicali M, D'Abundo L, Sabbioni S, Negrini M.

Cell Death Differ. 2015 Jan;22(1):46-57. doi: 10.1038/cdd.2014.136. Epub 2014 Sep 5. Review.

16.

microRNAome expression in chronic lymphocytic leukemia: comparison with normal B-cell subsets and correlations with prognostic and clinical parameters.

Negrini M, Cutrona G, Bassi C, Fabris S, Zagatti B, Colombo M, Ferracin M, D'Abundo L, Saccenti E, Matis S, Lionetti M, Agnelli L, Gentile M, Recchia AG, Bossio S, Reverberi D, Rigolin G, Calin GA, Sabbioni S, Russo G, Tassone P, Morabito F, Ferrarini M, Neri A.

Clin Cancer Res. 2014 Aug 1;20(15):4141-53. doi: 10.1158/1078-0432.CCR-13-2497. Epub 2014 Jun 10.

17.

p53/mdm2 feedback loop sustains miR-221 expression and dictates the response to anticancer treatments in hepatocellular carcinoma.

Fornari F, Milazzo M, Galassi M, Callegari E, Veronese A, Miyaaki H, Sabbioni S, Mantovani V, Marasco E, Chieco P, Negrini M, Bolondi L, Gramantieri L.

Mol Cancer Res. 2014 Feb;12(2):203-16. doi: 10.1158/1541-7786.MCR-13-0312-T. Epub 2013 Dec 9.

18.

Anti-tumor activity of a miR-199-dependent oncolytic adenovirus.

Callegari E, Elamin BK, D'Abundo L, Falzoni S, Donvito G, Moshiri F, Milazzo M, Altavilla G, Giacomelli L, Fornari F, Hemminki A, Di Virgilio F, Gramantieri L, Negrini M, Sabbioni S.

PLoS One. 2013 Sep 12;8(9):e73964. doi: 10.1371/journal.pone.0073964. eCollection 2013.

19.

Role of microRNAs in hepatocellular carcinoma: a clinical perspective.

Callegari E, Elamin BK, Sabbioni S, Gramantieri L, Negrini M.

Onco Targets Ther. 2013 Sep 2;6:1167-78. doi: 10.2147/OTT.S36161. Review.

20.

miR-221 affects multiple cancer pathways by modulating the level of hundreds messenger RNAs.

Lupini L, Bassi C, Ferracin M, Bartonicek N, D'Abundo L, Zagatti B, Callegari E, Musa G, Moshiri F, Gramantieri L, Corrales FJ, Enright AJ, Sabbioni S, Negrini M.

Front Genet. 2013 Apr 25;4:64. doi: 10.3389/fgene.2013.00064. eCollection 2013.

21.

Liver tumorigenicity promoted by microRNA-221 in a mouse transgenic model.

Callegari E, Elamin BK, Giannone F, Milazzo M, Altavilla G, Fornari F, Giacomelli L, D'Abundo L, Ferracin M, Bassi C, Zagatti B, Corrà F, Miotto E, Lupini L, Bolondi L, Gramantieri L, Croce CM, Sabbioni S, Negrini M.

Hepatology. 2012 Sep;56(3):1025-33. doi: 10.1002/hep.25747. Epub 2012 Jul 13.

PMID:
22473819
22.

In hepatocellular carcinoma miR-519d is up-regulated by p53 and DNA hypomethylation and targets CDKN1A/p21, PTEN, AKT3 and TIMP2.

Fornari F, Milazzo M, Chieco P, Negrini M, Marasco E, Capranico G, Mantovani V, Marinello J, Sabbioni S, Callegari E, Cescon M, Ravaioli M, Croce CM, Bolondi L, Gramantieri L.

J Pathol. 2012 Jul;227(3):275-85. doi: 10.1002/path.3995. Epub 2012 Apr 18.

PMID:
22262409
23.

MINT31 methylation in gastric noninvasive neoplasia: potential role in the secondary prevention of gastric cancer.

Negrini M, Miotto E, Sabbioni S, Cardin R, Rugge M, Tieppo C, Piciocchi M, Maddalo G, Nitti D, Farinati F.

Eur J Cancer Prev. 2012 Sep;21(5):442-8. doi: 10.1097/CEJ.0b013e32834f7536.

PMID:
22179688
24.

microRNA involvement in hepatocellular carcinoma.

Negrini M, Gramantieri L, Sabbioni S, Croce CM.

Anticancer Agents Med Chem. 2011 Jul;11(6):500-21. Review.

PMID:
21554203
25.

MicroRNA response to environmental mutagens in liver.

Elamin BK, Callegari E, Gramantieri L, Sabbioni S, Negrini M.

Mutat Res. 2011 Dec 1;717(1-2):67-76. doi: 10.1016/j.mrfmmm.2011.03.015. Epub 2011 Apr 14. Review.

PMID:
21514310
26.

MicroRNA-221 targets Bmf in hepatocellular carcinoma and correlates with tumor multifocality.

Gramantieri L, Fornari F, Ferracin M, Veronese A, Sabbioni S, Calin GA, Grazi GL, Croce CM, Bolondi L, Negrini M.

Clin Cancer Res. 2009 Aug 15;15(16):5073-81. doi: 10.1158/1078-0432.CCR-09-0092. Epub 2009 Aug 11.

27.

MiR-122/cyclin G1 interaction modulates p53 activity and affects doxorubicin sensitivity of human hepatocarcinoma cells.

Fornari F, Gramantieri L, Giovannini C, Veronese A, Ferracin M, Sabbioni S, Calin GA, Grazi GL, Croce CM, Tavolari S, Chieco P, Negrini M, Bolondi L.

Cancer Res. 2009 Jul 15;69(14):5761-7. doi: 10.1158/0008-5472.CAN-08-4797. Epub 2009 Jul 7.

28.

MicroRNA involvement in hepatocellular carcinoma.

Gramantieri L, Fornari F, Callegari E, Sabbioni S, Lanza G, Croce CM, Bolondi L, Negrini M.

J Cell Mol Med. 2008 Dec;12(6A):2189-204. doi: 10.1111/j.1582-4934.2008.00533.x. Review.

29.

MicroRNA expression changes during human leukemic HL-60 cell differentiation induced by 4-hydroxynonenal, a product of lipid peroxidation.

Pizzimenti S, Ferracin M, Sabbioni S, Toaldo C, Pettazzoni P, Dianzani MU, Negrini M, Barrera G.

Free Radic Biol Med. 2009 Jan 15;46(2):282-8. doi: 10.1016/j.freeradbiomed.2008.10.035. Epub 2008 Oct 30.

PMID:
19022373
30.

MiR-221 controls CDKN1C/p57 and CDKN1B/p27 expression in human hepatocellular carcinoma.

Fornari F, Gramantieri L, Ferracin M, Veronese A, Sabbioni S, Calin GA, Grazi GL, Giovannini C, Croce CM, Bolondi L, Negrini M.

Oncogene. 2008 Sep 25;27(43):5651-61. doi: 10.1038/onc.2008.178. Epub 2008 Jun 2.

PMID:
18521080
31.

Open letter to Senator Rita Levi-Montalcini.

Clementi R, Bargigli L, Sabbioni S, Levi-Montalcini R.

Science. 2008 Mar 21;319(5870):1615. doi: 10.1126/science.319.5870.1615b. No abstract available.

PMID:
18356504
32.

The methylator phenotype in microsatellite stable colorectal cancers is characterized by a distinct gene expression profile.

Ferracin M, Gafà R, Miotto E, Veronese A, Pultrone C, Sabbioni S, Lanza G, Negrini M.

J Pathol. 2008 Apr;214(5):594-602. doi: 10.1002/path.2318.

PMID:
18241079
33.

Simian virus 40 in humans.

Martini F, Corallini A, Balatti V, Sabbioni S, Pancaldi C, Tognon M.

Infect Agent Cancer. 2007 Jul 9;2:13.

34.

Cyclin G1 is a target of miR-122a, a microRNA frequently down-regulated in human hepatocellular carcinoma.

Gramantieri L, Ferracin M, Fornari F, Veronese A, Sabbioni S, Liu CG, Calin GA, Giovannini C, Ferrazzi E, Grazi GL, Croce CM, Bolondi L, Negrini M.

Cancer Res. 2007 Jul 1;67(13):6092-9.

35.

MicroRNAs in human cancer: from research to therapy.

Negrini M, Ferracin M, Sabbioni S, Croce CM.

J Cell Sci. 2007 Jun 1;120(Pt 11):1833-40.

36.

Nidogen 1 and 2 gene promoters are aberrantly methylated in human gastrointestinal cancer.

Ulazzi L, Sabbioni S, Miotto E, Veronese A, Angusti A, Gafà R, Manfredini S, Farinati F, Sasaki T, Lanza G, Negrini M.

Mol Cancer. 2007 Feb 28;6:17.

37.

Anticancer activity of an adenoviral vector expressing short hairpin RNA against BK virus T-ag.

Sabbioni S, Callegari E, Spizzo R, Veronese A, Altavilla G, Corallini A, Negrini M.

Cancer Gene Ther. 2007 Mar;14(3):297-305. Epub 2007 Jan 12.

PMID:
17218949
38.

Use of herpes simplex virus type 1-based amplicon vector for delivery of small interfering RNA.

Sabbioni S, Callegari E, Manservigi M, Argnani R, Corallini A, Negrini M, Manservigi R.

Gene Ther. 2007 Mar;14(5):459-64. Epub 2006 Oct 19.

PMID:
17051250
39.

BK virus, JC virus and Simian Virus 40 infection in humans, and association with human tumors.

Barbanti-Brodano G, Sabbioni S, Martini F, Negrini M, Corallini A, Tognon M.

Adv Exp Med Biol. 2006;577:319-41. Review. No abstract available.

PMID:
16626046
40.

MicroRNA gene expression deregulation in human breast cancer.

Iorio MV, Ferracin M, Liu CG, Veronese A, Spizzo R, Sabbioni S, Magri E, Pedriali M, Fabbri M, Campiglio M, Ménard S, Palazzo JP, Rosenberg A, Musiani P, Volinia S, Nenci I, Calin GA, Querzoli P, Negrini M, Croce CM.

Cancer Res. 2005 Aug 15;65(16):7065-70.

41.

Frequent aberrant methylation of the CDH4 gene promoter in human colorectal and gastric cancer.

Miotto E, Sabbioni S, Veronese A, Calin GA, Gullini S, Liboni A, Gramantieri L, Bolondi L, Ferrazzi E, Gafà R, Lanza G, Negrini M.

Cancer Res. 2004 Nov 15;64(22):8156-9.

42.

Multigene methylation analysis of gastrointestinal tumors: TPEF emerges as a frequent tumor-specific aberrantly methylated marker that can be detected in peripheral blood.

Sabbioni S, Miotto E, Veronese A, Sattin E, Gramantieri L, Bolondi L, Calin GA, Gafà R, Lanza G, Carli G, Ferrazzi E, Feo C, Liboni A, Gullini S, Negrini M.

Mol Diagn. 2003;7(3-4):201-7.

PMID:
15068392
43.

Simian virus 40 infection in humans and association with human diseases: results and hypotheses.

Barbanti-Brodano G, Sabbioni S, Martini F, Negrini M, Corallini A, Tognon M.

Virology. 2004 Jan 5;318(1):1-9. Review.

PMID:
15015494
44.

Prevalence of liver tumours in HIV-1 tat-transgenic mice treated with urethane.

Altavilla G, Caputo A, Trabanelli C, Brocca Cofano E, Sabbioni S, Menegatti MA, Barbanti-Brodano G, Corallini A.

Eur J Cancer. 2004 Jan;40(2):275-83.

PMID:
14728943
45.

t(4;11)(q21;p15) translocation involving NUP98 and RAP1GDS1 genes: characterization of a new subset of T acute lymphoblastic leukaemia.

Mecucci C, La Starza R, Negrini M, Sabbioni S, Crescenzi B, Leoni P, Di Raimondo F, Krampera M, Cimino G, Tafuri A, Cuneo A, Vitale A, Foà R.

Br J Haematol. 2000 Jun;109(4):788-93.

PMID:
10929031
46.

Acquired chromosome 11q deletion involving the ataxia teleangiectasia locus in B-cell non-Hodgkin's lymphoma: correlation with clinicobiologic features.

Cuneo A, Bigoni R, Rigolin GM, Roberti MG, Milani R, Bardi A, Minotto C, Agostini P, De Angeli C, Narducci MG, Sabbioni S, Russo G, Negrini M, Castoldi G.

J Clin Oncol. 2000 Jul;18(13):2607-14.

PMID:
10893293
47.

Exon structure and promoter identification of STIM1 (alias GOK), a human gene causing growth arrest of the human tumor cell lines G401 and RD.

Sabbioni S, Veronese A, Trubia M, Taramelli R, Barbanti-Brodano G, Croce CM, Negrini M.

Cytogenet Cell Genet. 1999;86(3-4):214-8.

PMID:
10575208
48.

Subchromosomal assignment1 of the TSSC1 gene to human chromosome band 11p15.5 near the HBB gene cluster.

Scelfo R, Sabbioni S, Barbanti-Brodano G, Negrini M.

Cytogenet Cell Genet. 1998;83(1-2):52-3. No abstract available.

PMID:
9925925
49.

Transcriptional map of 170-kb region at chromosome 11p15.5: identification and mutational analysis of the BWR1A gene reveals the presence of mutations in tumor samples.

Schwienbacher C, Sabbioni S, Campi M, Veronese A, Bernardi G, Menegatti A, Hatada I, Mukai T, Ohashi H, Barbanti-Brodano G, Croce CM, Negrini M.

Proc Natl Acad Sci U S A. 1998 Mar 31;95(7):3873-8.

50.

GOK: a gene at 11p15 involved in rhabdomyosarcoma and rhabdoid tumor development.

Sabbioni S, Barbanti-Brodano G, Croce CM, Negrini M.

Cancer Res. 1997 Oct 15;57(20):4493-7.

Supplemental Content

Loading ...
Support Center